x
Elara Pharmaceuticals Ltd - Logo
[contact-form-7 404 "Not Found"]

  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • 666-888-0000
  • info@elarapharma.com
Elara Pharmaceuticals Ltd - Logo
  • info@elarapharma.com
  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • Contact Us
  • Home
  • About Us
  • Our Business
  • Our Technology
  • Real World Data
  • News
    • In The News
    • Publications
  • Careers
Logo

Contact Info

  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • +44 20 8040 0302
  • info@elarapharma.com
Precision Medicine

May2016

Tersan Science Day (Paris | May 9)

Tersan hosted their regular Science Day this week – a 1-day symposium in Paris on advances in machine learning and artificial intelligence, chaired by Dr Jean Sallantin, Director of Research at the CNRS LIRMM (Laboratoire d’Informatique, de Robotique et de Micro-électronique de Montpellier) and Scientific Advisor to Tersan.   As ever, this was a stimulating […]

Read More
Precision Medicine

Apr2016

NoFinishLine Paris 2016 (Paris | April 13)

The Tersan Running Team are pleased to participate in the popular NoFinishLine Paris 2016 charitable fun run event in support of sick and homeless children.   Tersan Running Team at NoFinishLine Paris 2016 (Left to right): Sébastien Vaucouleur, Isabelle Chaduteau, Dan Manak, Mohammad Afshar, Yannic Tognetti, Sylke Ingeborg Müller (11254), David Morley, Vincent Récamier, Julie Miralves, […]

Read More
Cancer

Jun2015

WIN 2015 Symposium (Paris | 29-30 June)

Dr Mohammad Afshar (Founder and CEO) is presenting our Onco KEM® platform at WIN 2015 on 29 June. Dr. Mariana Guergova-Kuras (CTO) and Dr David Morley (VP Computational Technology) will also be attending the symposium for a fascinating two days of cutting-edge presentations and discussions with global key opinion leaders in cancer research and precision cancer […]

Read More
Cancer

Jun2015

Tersan® Pharma teams together with SIB Swiss Institute of Bioinformatics to discover novel biomarkers for gastric cancer

Leader in clinical big data analytics collaborates with world-class bioinformatics provider in GastricGlycoExplorer consortiumPartnership to develop early detection tools for one of the deadliest cancers Links: Download English PDF | Download French PDF Paris, France, Cambridge, Massachusetts USA, and Geneva, Switzerland, 1 June 2015 – Elara Pharmaceuticals Ltd, developer of innovative clinical data analysis and diagnostic […]

Read More
Cancer

Jan2015

Nabsys and Elara Pharmaceuticals Ltd Collaborate to Identify DNA Structural Variants Linked to Targeted Cancers

Nabsys will collaborate with Elara Pharmaceuticals Ltd to identify structural variations related to breast and prostate cancer and how they affect clinical outcome of patients. Links: Download English PDF Providence, Rhode Island, USA, and Paris, FRANCE – January 12th , 2015 – Nabsys, Inc., a life sciences company pioneering semiconductor-based tools for human genomic analysis in […]

Read More
Cancer

Dec2014

Onco KEM(R) platform for personalized cancer treatment selection

Elara Pharmaceuticals Ltd releases a video to illustrate its innovative Onco KEM® platform for personalized cancer treatment selection. Onco KEM® intends to accelerate the translation of personalized medicine discoveries into widely available new standards of care for all cancer patients, leading to significantly improved clinical outcomes and a higher quality of life for cancer patients.   […]

Read More
Precision Medicine

Dec2014

Colloque scientifique annuel du Technion (Paris | December 15)

Dr Mohammad Afshar (Founder and CEO) is joining a prestigious panel of industry leaders to discuss the strategy of open data, data intelligence and data management. Genevieve Fioraso, France’s Deputy Minister for Higher Education & Research and Axelle Lemaire, Deputy Minister in charge of digital tech will participate in the session. Making Sense of BIG […]

Read More
Precision Medicine

Dec2014

GEN corporate profile: Tersan’s Analytics Aim at Predictive Power

Specialist Company Strives to Improve Patient Selection and Treatment Outcomes. Elara Pharmaceuticals Ltd exhaustively mines and analyzes multiparametric data (biochemical, genomic, proteomic, genetic, metabolic, imaging, clinical, etc.) to identify patient responders and reduce clinical and drug development risks. The process generates actionable information using fewer biomarker signatures than traditional data-mining methods, improving both efficiency and efficacy. […]

Read More
Cancer

Oct2014

Elara Pharmaceuticals Ltd joins the WIN Consortium as official technology partner

Leader in clinical big data analytics collaborates with global stakeholders in personalized cancer medicine. Partnership to accelerate translation of personalized medicine discoveries into widely available new standards of care for all cancer patients. Links: Download English PDF | Download French PDF Paris, France, and Cambridge, Massachusetts USA, 29 October 2014 – Elara Pharmaceuticals Ltd, developer of […]

Read More
Kidney Transplant

Jul2014

EACR-23: Shorter multimarker signatures: a new tool to facilitate cancer diagnosis

KEM® Biomarker case study presented at EACR-23 this week showed that prognostic signatures generated by KEM® Biomarker have better or similar performances to other classification methods in terms of sensitivity and specificity while having significantly lower number of features in the models. 23rd Biennial Congress of the European Association for Cancer Research. From Basic Research […]

Read More

Posts navigation

1 … 3 4 5 6

Categories

  • Alzheimer's
  • Autism
  • Autoimmune disease
  • Cancer
  • Fibromyalgia
  • Kidney Transplant
  • Parkinson’s
  • Precision Medicine
  • Publications
  • Real World Evidence
  • Recent Posts
  • Type A Diabetes

Tags

alzheimer's autism cancer Event Fibromyalgia Graft rejection Influenza Kidney Laboratory lung neurological Oncology Professor Jean-Yves BLAY Centre Leon berard Parkinson Parkinson’s precisionmedicine precision medicine publication realworldevidence recent post Recent Posts Research Transplant vaccine

Elara Pharmaceuticals Ltd, The AI DRUG Development Company

  • The Barn Holly Berry House Rough Park,
    Hamstall Ridware, Rugeley, Staffordshire, WS15 3SQ
  • Call Us: +44 20 8040 0302
  • info@elarapharma.com

Menu

  • About Us
  • Our business
  • Technology
  • In The News
  • Contact Us

Subscribe

Keep in touch and subscribe to our latest news

    Elara Pharmaceuticals Ltd © 2024 All Rights Reserved